Skip to content

Cumberland Pharmaceuticals CPIX Operating Lease Liabilities (Current)

Operating Lease Liabilities (Current) at other companies

PTH
Pelthos Therapeutics Inc.PTHS
$640K
Rigel Pharmaceuticals logo
Rigel PharmaceuticalsRIGL
$636K+39.5%
BridgeBio Pharma logo
BridgeBio PharmaBBIO
$4.44M-14.8%
Opko Health logo
Opko HealthOPK
$11.09M+12.1%
Mirum Pharmaceuticals, Inc. logo
Mirum Pharmaceuticals, Inc.MIRM
$2.35M+43.1%
Viatris logo
ViatrisVTRS
$101.7M-1.5%

Other financials

Income statement

See full
Revenue$9.1M-22.0%
Gross profit$7.2M-30.0%
Operating income-$3.1M-342%
Net income-$3.3M-362%
EPS (diluted)-$0.22-375%

Balance sheet

See full
Cash & equivalents$11.0M-27.1%
Total debt$4.8M-7.1%
Total equity$21.6M-24.5%
Total assets$71.0M+1.5%

Cash flow

See full
Operating cash flow$387.0K-90.1%
CapEx--100%
Free cash flow$387.0K-89.9%

Valuation

See full
Market cap$97.09M+138%
Enterprise value$90.91M+207%
P/S2.3×+1.3×

Profitability

See full
Gross margin82.9%-1.4pp
Operating margin-17.2%-125pp
Net margin-17.6%-103pp
FCF margin3.3%

Returns & leverage

See full
Return on equity-29.4%-86.3pp
Debt / equity0.2×0.0×
Current ratio-0.3×

Where this comes from

Reported directly by Cumberland Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseLiabilityCurrent.

The official record: Cumberland Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Cumberland Pharmaceuticals's operating lease liabilities (current).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Cumberland Pharmaceuticals's operating lease liabilities (current)?
Cumberland Pharmaceuticals (CPIX) reported operating lease liabilities (current) of $485.16K in Q1 2026.
How has Cumberland Pharmaceuticals's operating lease liabilities (current) changed year-over-year?
Cumberland Pharmaceuticals's operating lease liabilities (current) increased by 30.7% year-over-year, from $371.09K to $485.16K.
What is the long-term trend for Cumberland Pharmaceuticals's operating lease liabilities (current)?
Over 5 years (2020 to 2025), Cumberland Pharmaceuticals's operating lease liabilities (current) has grown at a -14.4% compound annual growth rate (CAGR), from $1.02M to $467.77K.
What does operating lease liabilities (current) mean?
The current portion of operating lease obligations due within one year, representing committed future lease payments under ASC 842.